Patents by Inventor Frank Neipel

Frank Neipel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Viral interleukin-6
    Patent number: 7968696
    Abstract: The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.
    Type: Grant
    Filed: July 19, 1996
    Date of Patent: June 28, 2011
    Assignees: Behring Diagnostics GmbH, New York University
    Inventors: Bernhard Fleckenstein, Jens-Christian Albrecht, Frank Neipel, Alvin Friedman-Kien, Yao-Qi Huang
  • Viral interleukin-6
    Patent number: 7109002
    Abstract: The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: September 19, 2006
    Assignees: New York University School of Medicine, BehringDiagnostics GmbH
    Inventors: Bernhard Fleckenstein, Jens Christian Albrecht, Frank Neipel, Alvin Friedman-Kien, Yao Qi Huang
  • Viral interleukin-6
    Publication number: 20040228838
    Abstract: The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.
    Type: Application
    Filed: April 21, 2004
    Publication date: November 18, 2004
    Applicants: Behring Diagnostics GmbH, New York University
    Inventors: Bernhard Fleckenstein, Jens-Christian Albrecht, Frank Neipel, Alvin Friedman-Kien, Yao Qi Huang
  • Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy
    Patent number: 6177080
    Abstract: The invention relates to polypeptides of the Kaposi sarcoma-associated herpes virus which have a part-sequence of at least 10 consecutive amino acids from the sequence Met Ser Ser Thr Gln Ile Arg Thr Glu Ile Pro Val Ala Leu Leu Ile Leu Cys Leu Cys Leu Val Ala Cys His Ala Asn Cys Pro Thr Tyr Arg Ser His Leu Gly Phe Trp Gln Glu Gly Trp Ser Gly Gln Val Tyr Gln Asp Trp Leu Gly Arg Met Asn Cys Ser Tyr Glu Asn Met Thr Ala Leu Glu Ala Val Ser Leu Asn Gly Thr Arg Leu Ala Ala Gly Ser Pro Ser Ser Glu Tyr Pro Asn Val Ser Val Ser Val Glu Asp Thr Ser Ala Ser Gly Ser Gly Glu Asp Ala Ile Asp Glu Ser Gly Ser Gly Glu Glu Glu Arg Pro Val Thr Ser His Val Thr Phe Met Thr Gln Ser Val Gln Ala Thr Thr Glu Leu Thr Asp Ala Leu Ile Ser Ala Phe Ser Gly Val Leu His Val Ser Thr Val Ile Pro Arg Asn Trp Val Asn Arg Arg Cys Val Gly Ile Lys Arg Asn Leu Thr Phe
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: January 23, 2001
    Assignee: Biotest AG
    Inventors: Bernhard Fleckenstein, Jens-Christian Albrecht, Frank Neipel, Dieter Lang
  • Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
    Patent number: 6174685
    Abstract: The invention relates to the human herpesvirus type 6 protein p100 and parts thereof having its specific immunological properties. It further relates to antibodies directed to them and to the corresponding DNA sequences. They can be used in pharmaceutical or diagnostic compositions, optionally together with other HHV-6 proteins or the corresponding DNA sequences.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 16, 2001
    Assignee: Behring Diagnostics GmbH
    Inventors: Frank Neipel, Bernhard Fleckenstein
  • Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
    Patent number: 5827519
    Abstract: The invention relates to the human herpesvirus type 6 protein p100 and parts thereof having its specific immunological properties. It further relates to antibodies directed to them and to the corresponding DNA sequences. They can be used in pharmaceutical or diagnostic compositions, optionally together with other HHV-6 proteins or the corresponding DNA sequences.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 27, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Frank Neipel, Bernhard Fleckenstein
  • Human herpesvirus type 6 protein p100, the corresponding DNA seqences, their preparation and use
    Patent number: 5814475
    Abstract: The invention relates to the human herpesvirus type 6 protein p100 and parts thereof having its specific immunological properties. It further relates to antibodies directed to them and to the corresponding DNA sequences. They can be used in pharmaceutical or diagnostic compositions, optionally together with other HHV-6 proteins or the corresponding DNA sequences.
    Type: Grant
    Filed: June 27, 1994
    Date of Patent: September 29, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Frank Neipel, Bernhard Fleckenstein